FREQUENCY ELECTRONICS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FREQUENCY ELECTRONICS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $69.81M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $55.27M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $40.78M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $48.30M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $54.25M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | $41.51M | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | $49.51M | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | $39.41M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $50.35M | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $55.42M | Jul 31, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $30.10M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $18.58M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $7.85M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $8.60M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $16.92M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | $5.75M | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | $15.79M | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | $5.16M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $11.25M | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $19.28M | Jul 31, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $23.69M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $5.59M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | ($5.50M) | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | ($8.66M) | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $680.0K | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | ($10.03M) | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | ($2.53M) | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | ($23.78M) | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | ($4.82M) | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $1.01M | Jul 31, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $11.73M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $5.02M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | ($4.67M) | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | ($8.04M) | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | ($958.0K) | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | ($10.92M) | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | ($2.82M) | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | ($12.40M) | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | ($7.53M) | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $2.47M | Jul 31, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $6.08M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $3.38M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $3.15M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $4.98M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $4.69M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | $5.08M | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | $6.51M | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | $6.95M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $6.88M | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $5.43M | Jul 31, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $12.29M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $10.18M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $9.37M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $11.66M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $13.19M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | $11.59M | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | $12.10M | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | $10.61M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $11.90M | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $11.38M | Jul 31, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($1.43M) | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $8.71M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $1.18M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $4.04M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $12.16M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | ($1.41M) | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | ($97.0K) | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | $4.53M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $3.89M | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $2.92M | Jul 31, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.81M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $1.49M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $918.0K | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $1.86M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $1.24M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | $1.48M | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | $2.77M | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | $1.42M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $5.23M | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $3.26M | Jul 31, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $93.74M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $83.25M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $74.50M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $84.76M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $98.53M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | $91.28M | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | $86.77M | Jul 29, 2020 |
| FY2019 | May 1, 2018 | $84.18M | Jul 26, 2019 |
| FY2019 | Apr 30, 2018 | $83.58M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $113.32M | Jul 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $38.12M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $43.44M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $41.61M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $38.07M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $43.12M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | $37.04M | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | $23.68M | Jul 29, 2020 |
| FY2019 | May 1, 2018 | $20.43M | Jul 26, 2019 |
| FY2019 | Apr 30, 2018 | $20.32M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $23.99M | Jul 30, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $55.62M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $39.82M | Jul 18, 2025 |
| FY2025 | Apr 30, 2023 | $32.89M | Jul 18, 2025 |
| FY2024 | Apr 30, 2022 | $46.69M | Aug 2, 2024 |
| FY2023 | Apr 30, 2021 | $55.41M | Jul 27, 2023 |
| FY2022 | Apr 30, 2020 | $54.24M | Dec 21, 2022 |
| FY2021 | Apr 30, 2019 | $63.09M | Jun 30, 2021 |
| FY2019 | May 1, 2018 | $63.75M | Jul 26, 2019 |
| FY2020 | Apr 30, 2018 | $63.26M | Jul 29, 2020 |
| FY2019 | Apr 30, 2017 | $89.33M | Jul 26, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $617.0K | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $617.0K | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $617.0K | Aug 2, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $3.66M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | ($20.03M) | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | ($25.62M) | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | ($20.12M) | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | ($11.46M) | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | ($12.14M) | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | ($2.11M) | Jul 29, 2020 |
| FY2019 | May 1, 2018 | $419.0K | Jul 26, 2019 |
| FY2019 | Apr 30, 2018 | ($65.0K) | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | $23.71M | Jul 30, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $4.72M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | $18.32M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | $12.05M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | $11.56M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | $9.81M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | $3.81M | Jun 30, 2021 |
| FY2021 | Apr 30, 2019 | $3.68M | Jun 30, 2021 |
| FY2020 | Apr 30, 2018 | $7.87M | Jul 29, 2020 |
| FY2018 | Apr 30, 2017 | $2.16M | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | $5.82M | Jul 31, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 2 | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 18, 2025 |
| FY2017 | Apr 30, 2017 | 0 | Jul 31, 2017 |
| FY2017 | Apr 30, 2016 | 0 | Jul 31, 2017 |
| FY2016 | Apr 30, 2015 | 0 | Jul 29, 2016 |
| FY2015 | Apr 30, 2014 | 0 | Jul 29, 2015 |
| FY2014 | Apr 30, 2013 | 0 | Jul 29, 2014 |
| FY2013 | Apr 30, 2012 | 0 | Jul 29, 2013 |
| FY2012 | Apr 30, 2011 | 0 | Jul 30, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 2 | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 18, 2025 |
| FY2017 | Apr 30, 2017 | 0 | Jul 31, 2017 |
| FY2017 | Apr 30, 2016 | 0 | Jul 31, 2017 |
| FY2016 | Apr 30, 2015 | 0 | Jul 29, 2016 |
| FY2015 | Apr 30, 2014 | 0 | Jul 29, 2015 |
| FY2014 | Apr 30, 2013 | 0 | Jul 29, 2014 |
| FY2013 | Apr 30, 2012 | 0 | Jul 29, 2013 |
| FY2012 | Apr 30, 2011 | 0 | Jul 30, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 9.70M | Jul 18, 2025 |
| FY2025 | Apr 30, 2024 | 9.51M | Jul 18, 2025 |
| FY2024 | Apr 30, 2023 | 9.37M | Aug 2, 2024 |
| FY2023 | Apr 30, 2022 | 9.30M | Jul 27, 2023 |
| FY2022 | Apr 30, 2021 | 9.23M | Dec 21, 2022 |
| FY2021 | Apr 30, 2020 | 9.12M | Jun 30, 2021 |
| FY2020 | Apr 30, 2019 | 8.98M | Jul 29, 2020 |
| FY2019 | Apr 30, 2018 | 8.87M | Jul 26, 2019 |
| FY2018 | Apr 30, 2017 | 8.82M | Jul 30, 2018 |
| FY2017 | Apr 30, 2016 | 8.75M | Jul 31, 2017 |